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Abstract
Introduction: Indigenous Australians suffer markedly higher rates of end-stage kidney disease (ESKD) but are less
likely than their non-Indigenous counterparts to receive a transplant. This difference is not fully explained by
measurable clinical differences. Previous work suggests that Indigenous Australian patients may be regarded by
treating specialists as ‘non-compliers’, which may negatively impact on referral for a transplant. However, this
decision-making is not well understood. The objectives of this study were to investigate: whether Indigenous
patients are commonly characterised as ‘non-compliers’; how estimations of patient compliance factor into
Australian nephrologists’ decision-making about transplant referral; and whether this may pose a particular barrier
for Indigenous patients accessing transplants.
Methods: Nineteen nephrologists, from eight renal units treating the majority of Indigenous Australian renal
patients, were interviewed in 2005-06 as part of a larger study. Thematic analysis was undertaken to investigate
how compliance factors in specialists’ decision-making, and its implications for Indigenous patients’ likelihood of
obtaining transplants.
Results: Specialists commonly identified Indigenous patients as both non-compliers and high-risk transplant
candidates. Definition and assessment of ‘compliance’ was neither formal nor systematic. There was uncertainty
about the value of compliance status in predicting post-transplant outcomes and the issue of organ scarcity
permeated participants’ responses. Overall, there was marked variation in how specialists weighed perceptions of
compliance and risk in their decision-making.
Conclusion: Reliance on notions of patient ‘compliance’ in decision-making for transplant referral is likely to result
in continuing disadvantage for Indigenous Australian ESKD patients. In the absence of robust evidence on
predictors of post-transplant outcomes, referral decision-making processes require attention and debate.
Keywords: Kidney transplantation, Indigenous peoples, Aboriginal and Torres Strait Islander, Compliance
Introduction
End-stage kidney disease (ESKD) affects Indigenous
Australians disproportionately [1]. Transplantation is the
optimal treatment [2], but there is a substantial and per-
sistent disparity in transplants given to Indigenous and
non-Indigenous patients [3] .T h ev a s tm a j o r i t yo fI n d i -
genous Australians with ESKD remain on life-long dialy-
sis. Their lower probability of receiving a transplant is
not fully explained by measurable clinical differences.
Many Indigenous Australians share contextual factors
that may detrimentally affect their engagement with the
health system and their response to the significant per-
sonal demands imposed by dialysis regimens. As a
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vantage, lower educational attainment and poorer health
literacy [4]. Many Indigenous dialysis patients experi-
ence isolation and reduced engagement in treatment
management [5,6], particularly for those needing to
move permanently from rural and remote home com-
munities to obtain dialysis services [7].
With donor kidneys very scarce, clinical decision-mak-
ing and allocation are often difficult to separate. Practi-
tioners struggle with dual loyalties - to their patient and,
to managing a scarce resource [8]. Despite most trans-
plant programs using guidelines to identify suitable can-
didates [9], decision-making processes are poorly
understood [10]. While referring kidney specialists need
confidence that the recipient will benefit, the organ
shortage might deter them from referring relatively
‘risky’ patients, irrespective of the benefit those patients
may derive.
Referral to a transplant program is a crucial step
towards securing a transplant. The nephrologist must
identify the patient as potentially suitable and refer him
or her for screening. While this sounds straightforward,
the decision is within an environment of scarce resource
availability, time constraints, imperfect information and
contested ethical frameworks for allocation. Geographic
remoteness and language and cultural differences further
complicate referral. It is necessary to understand referral
decision-making within these limitations to assess the
barriers facing Indigenous patients.
’Compliance’ as a predictor of post-transplantation risk
The use of compliance as a predictor of risk may particu-
larly disadvantage Indigenous patients. Previous research
suggests that a nephrologist’s perception of a patient’s
‘compliance’ with his or her dialysis regimen strongly
influences referral. An Australian survey using hypotheti-
cal patient vignettes revealed that ‘compliance’ (not
defined in the vignettes) was a highly significant indepen-
dent predictor of referral - second only to advanced age
[11]. The importance of perceived compliance was high-
lighted in a review of Australian selection guidelines; ‘non-
compliance’ - though poorly defined - is a contraindica-
tion, despite a lack of cited evidence, in seven of eight
guidelines examined [9]. These studies suggest that
nephrologists accord high priority to compliance and com-
monly see it as a prerequisite for referral.
Perceived non-compliance with pre-transplant dialysis
may be seen as a predictor of post-transplant non-compli-
ance. However, the treatment regimens differ markedly.
Haemodialysis demands thrice-weekly attendance, strict
fluid and dietary control and multiple medications. The
post-transplant regimen, by contrast, while requiring strict
adherence to medications, has fewer fluid and dietary
restrictions and, apart from the immediate post-transplant
period, few attendances. While non-compliance with
immunosuppressive medications is a recognised cause of
transplant failure, any association between pre- and post-
transplant non-compliance remains unclear [12-14].
The concept of compliance has been criticised in both
the social and medical literature [15,16] in particular
because it narrows the perspective on a complex situa-
tion [17,18]. Compliance focuses on particular patient
behaviours, while often overlooking the influences of sys-
temic and social factors. Behaviours interpreted as poor
compliance might stem from factors associated with low
socio-economic status and poorly-resourced medical ser-
vices [19]. The specific social and economic circum-
stances of many Indigenous Australians might make it
difficult for them to maintain the demanding dialysis
regimen. Uncertainty about transplant outcomes in this
population, together with the chronic organ scarcity,
might mean that Indigenous patients are regarded, in
general, as too high-risk.
Exploring nephrologists’ views about compliance and
suitability
We explored the views of Australian nephrologists about
compliance and transplant suitability - both generally and
specifically relating to Indigenous patients. This paper
draws on in-depth interviews conducted as part of a larger
program investigating the barriers facing Indigenous
ESKD patients in obtaining transplants. Thematic analysis
was undertaken to investigate how and why compliance is
factored into decision-making, and the implications for
Indigenous patients’ obtaining transplants.
Methods
A large interview study was conducted in 2005-6 as part
of the IMPAKT (Improving Access to Kidney Trans-
plants) study [20]. It investigated the reasons why so few
Indigenous Australians received transplants, through in-
depth interviews of Indigenous and non-Indigenous
patients, nephrologists and decision-making staff,.
IMPAKT established partnerships with a network of
transplant units and dialysis treatment centres treating
the vast majority of Indigenous patients. With the sup-
port of this network, the IMPAKT team interviewed peo-
ple in 26 treatment/service centres in metropolitan,
regional and remote Australia. A detailed account of the
overall study’s aims, methodology, ethical issues, recruit-
ment, sampling and data analysis are available elsewhere
[20].
The analysis reported in this paper focuses on the
interviews with the nephrologists. Two investigators
conducted semi-structured, in-depth interviews with 19
nephrologists. In most cases, interviews were conducted
individually and in person; three were conducted by tel-
ephone. All were audio recorded and later transcribed.
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patient compliance; decision-making about treatment
options; assessing suitability for transplant; transplant
processes; information and communication processes;
and the local renal and health service. This paper
focuses on the topic of compliance. The relevant ques-
tions explored the views and experiences of nephrolo-
gists on compliance and suita b i l i t y-w i t hap a r t i c u l a r
focus on Indigenous patients. All questions, with the
possible exception of compliance terminology itself,
employed value-neutral terms.
Participating nephrologists were asked the following
questions about patient compliance:
￿ Could you comment on what you understand by
the term ‘compliance’ and describe how you would
assess whether a patient is compliant?
￿ Are there any explicit and agreed upon criteria in
your unit to determine compliance status? If yes:
What are they?
￿ Are these criteria discussed with patients? At what
stage of their treatment would these be discussed?
￿ How and by whom is non-compliance documented
in your unit?
￿ What - if any - review or management processes
operate in your unit for patients who regularly fail
to comply with treatment?
￿ Have you put non-compliant patients on the wait-
ing list and/or recommended them for transplanta-
tion? Why (not)?
￿ Are there any particular circumstances or types of
patients for whom you make an exception?
￿ Are there any patient groups (say in terms of age,
gender, ethnicity or location) for whom you would
say that non-compliance is a particular issue? If yes:
Which groups?
￿ Have you had many non-compliant patients? If yes:
What would you say were the causes of their non-
compliance?
￿ Are there particular factors that lead a patient to
becoming non-compliant with treatment after
transplantation?
￿ Does this affect your decision about suitability for
transplant?
Participants
Eight large renal units and their associated dialysis ser-
vice centres, in five State/Territory jurisdictions, were
included because they treat the overwhelming majority of
Indigenous Australian patients with ESKD. The 19
nephrologists, both general nephrology and transplant
physicians, were purposively sampled to include the
views of key decision-makers at each site. Relevant
nephrologists were invited to attend information sessions
at each site and were subsequently invited to participate.
There were no Indigenous nephrologists in Australia at
the time the IMPAKT study was undertaken so hence all
interviewees were non-Indigenous.
Analysis
The data were analysed through content analysis of the
transcribed interviews using QSR NVivo 7 (Doncaster,
Australia). The major thematic groups were divided
between two investigators who coded all interviews.
Participant demographics were collected via self-
reporting. Descriptive statistics were generated using
SPSS 15.0 for Windows (Chicago, Illinois).
Ethical approval
The study was approved by 14 relevant jurisdictional
ethics committees, including six all- Indigenous commit-
tees. Site-based reference groups operated during the
course of the research at each of the nine hospital sites.
Results
The nephrologists’ discussions of compliance and trans-
plant suitability revealed complex decision-making - parti-
cularly relating to Indigenous patients. Reliance on
compliance was a common, yet contested, issue, which
significantly frustrated the nephrologists. The absolute
scarcity of organs affected approaches to resource alloca-
tion - particularly in relation to the risk of failure. Recur-
ring descriptions relating non-compliance among
Indigenous patients, to high-risk status and poor trans-
plant outcomes engendered a sense of caution, and some-
times reluctance, to refer them for transplant.
We explore here five inter-related issues that emerged
in the analysis:
￿ Poor definition and assessment of compliance;
￿ Uncertainty whether dialysis compliance predicts
post-transplant compliance;
￿ Divergent approaches to the equitable distribution of
scarce kidneys;
￿ Indigenous patients’ non-compliance linked to poor
outcomes; and
￿ Conflation of Indigenous non-compliance with
“culture”.
Poor definition and assessment of compliance
Asked to explain their understanding of ‘patient compli-
ance’, most specialists either gave a functional definition of
compliance or a description of how they assess compli-
ance. Essentially most referred to a variety of patient beha-
viours, attitudes and characteristics as markers of
compliance, including vaguely defined expectations that
patients engage with prescribed treatments and avoid
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either a formal definition or a shared understanding of
patient compliance among specialists.
Moreover, many were quick to point out flaws in their
own methods of assessing compliance which were criti-
cised by several as being subjective, non-quantitative
and involving more ‘gut-feeling’ [1-4] than measurement.
As one explained: I think it’s a subjective assessment . . .
which may or may not be accurate. [5-004]
Nephrologists agreed that compliance was difficult to
assess. Although some specialists cited possible assess-
ment methods, most spoke of it in only general terms, if
at all. Methods mentioned included clinic attendance
records, blood test results, checking medication packs,
patient self-reporting, family reporting, prescribing medi-
cations known to slow the heart rate and checking the
pulse rate, and intuition. However, none were reported as
being used consistently within or across units.
Uncertainty whether dialysis compliance predicts post-
transplant compliance
Ambivalence towards the relevance of compliance led to
markedly divergent views- both between specialists and
within interviews - on the predictive validity of estima-
tions of compliance to identify high-risk candidates.
Several noted that compliance does not translate from
dialysis to post-transplant settings because of dissimilari-
ties between the two treatment contexts. The difficulty
predicting uptake and maintenance of post-transplant
treatments is a source of great concern as explained by
one respondent: [It] is something that really worries us
immensely . . . I am totally unable to predict who may be
compliant with [post-transplant] medication and who
won’tb e .I ’ve had extraordinary lack of success with pre-
dicting that. [1-11]
Non-compliance was frequently identified as a ‘big con-
cern’ [1,2] and a key contraindication to transplantation.
Nevertheless, the majority said that they had, indeed,
recommended non-compliant patients for transplant.
Some nephrologists provided detailed accounts of
patients whose ‘compliance’ status changed after trans-
plantation - in both directions. Several suggested that
non-compliant patients pose too much of a risk to
receive such a scarce resource. However, even among
these specialists there was virtually unanimous agreement
that pre-transplant compliance was a poor predictor of
post-transplant behaviour and outcomes. For example,
although saying to one patient: If you can’tc o m p l yw i t h
dialysis, how do you expect me to trust you to comply
with transplantation? I have to give [transplants] to
patients who are going to take their pills because this is
what you have to do. [1] the nephrologist later went on
to say: I believe that it’s very difficult to say if someone’s
non-compliant on dialysis that they’r eg o i n gt ob en o n -
compliant with transplantation. I think the correlation
between the two is very difficult and there have been a
number of patients whom I’ve thought over the years
would never be compliant, who have been absolutely fine
when they’re transplanted, so I think that’s incredibly dif-
ficult to assess.[ 1 ]
Despite obvious frustration, the chief concern of many
- particularly in the context of extreme organ scarcity -
was forecasting whether or not a patient would maintain
the post-transplant regimen. One commented with some
resignation: Attitude to compliance is a major factor and
we regard that very closely. Because of the fact that there
will never be enough kidneys, if someone doesn’tt a k e
their medication, that stops someone else, so that’s a fac-
tor. And I think the hardest thing is how to determine
that.[ 1 ]
Divergent approaches to equitable distribution of scarce
resources
The scarcity of donor kidneys was a pervasive theme.
Almost every nephrologist identified it as a pressure in
decision-making. It clearly shaped many referral prac-
tices. Nevertheless there were fundamental differences
in nephrologists’ approaches to achieving an equitable
distribution of kidneys.
Severe organ scarcity creates strong tension between
clinician’s responsibilities to their individual patient and
their perceived (collective) responsibility to manage
organ distribution wisely. As one explained: Not only are
we in a position to try and make [patients] better . . . I
think we’re also paid to safeguard resources, you know,
society’sr e s o u r c e s...A n da l t h o u g hw e ’re trying to make
life better for this person, I think we could be judged
poorly if we, we squandered something you know . . . I
think it’s our job and our duty to make sure it’su s e d
wisely. [5-004] Another described the maximising the
benefit of the resource, rather than to equity of patient
access: Well I think the key barrier is organ availability
and the fact that we’re then forced to rank people based
on their suitability and potential benefit. Because we, in
our unit, have taken up that challenge and not said, “It’s
too hard”, and I think you can say “,It’st o oh a r d ”,a n d
just put everyone on the list. But I think that’sp r o b a b l y
not what society really needs [us] to do. [1-10] Another
specialist explained that his ultimate responsibility was to
the donor: [Transplant] isn’t a right, it’sag i f t ,a n dt h e
people giving the kidney have a right for it not to be
squandered. [5-004]
Conversely, a handful of specialists did not regard max-
imizing the utility of donated organs as the chief priority.
For them, the benefit to the individual was paramount:
We tend to transplant the Aboriginal patients in the hope
that they will be one of the group that does well. Now, you
could argue, that that’s not very evidence-based, nor is it
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cians who is bound by evidence, by cost utility . . . I think
[Aboriginal patients] deservet ob et r a n s p l a n t e d ,b e c a u s e
for those in whom there has been successful transplanta-
tion... it’s probably a greater advantage for them than it is
for the non-Indigenous, because the benefits in terms of
cultural and society are greater. They can go back where
they came from. [1-14]
These differences suggest that a ‘riskier’ candidate’s
likelihood of being referred - whether such risk is based
on medical, behavioural or circumstantial factors - could
depend strongly on where and by whom the patient was
being treated.
Indigenous non-compliance linked to poor transplant
outcomes
Indigenous patients were commonly categorised as high-
risk candidates. They were also thought to have worse
transplant outcomes than non-Indigenous recipients and
this belief was frequently associated with the view that
such patients had difficulties complying with treatment.
As one nephrologist said: ‘I think Indigenous patients
are over-represented in our non-compliant patients who
lose their kidneys from non-compliance.’ [1,2]
The view that Indigenous transplant outcomes were
relatively poor impacted on whether and how patients
were referred through a heightened sense of caution
increased scrutiny or “selectivity” of potential candidates,
as reflected here: I think within the unit, there is a gradual
acceptance that a more cautious approach to transplanta-
tion has met with better success than the previous
[approach] where ... everybody got listed because it was
thought unfair to delay Aboriginals. But the outcomes were
very unsatisfactory. So I think we are rewarded that a
more cautious and selective approach has value. [1-10]
Concerns about poor outcomes also extended to anxi-
eties about safety in transplanting Indigenous recipients
- whether or not transplantation might be considered
harmful. As one respondent explained: Well, that (recent
data on post-transplant survival for Indigenous patients)
reinforced my pre-existing impression that there is a
large number of patients, or a significant proportion of
patients from remote areas, who are actually disadvan-
taged, who actually die by being transplanted.[5-001]
Poor outcomes were most frequently ascribed to non-
compliance. As one respondent stated: I think the main
reason why - even if we think Indigenous patients are sui-
table - they don’t get on the list, is they’re at risk of com-
pliance problems. [1] Asked about outcomes, he said: I
believe they would be worse. I think it’s compliance. I
think it’s nearly always compliance . . . most Indigenous
patients’ transplants in our unit, and I will say most,
ended up with organ loss from (non) compliance. They’re
a small proportion, so you remember.[ 1 ]
Conflation of indigenous non-compliance with “culture”
Dialysis non-compliance was often conflated with per-
ceived social and cultural factors. Statements about Indi-
genous patients being non-compliant and high-risk
candidates were frequently enmeshed larger, more gen-
eralised accounts of their social difficulties and perceived
cultural particularities.
Factors repeatedly mentioned included living in a
remote location, low socio-economic status, alcohol abuse
and low levels of education. The comments of one
nephrologist illustrate how situational, cultural and social
factors are perceived to contribute: I think it’s partly belief
system - whether or not you believe the medication is going
to do anything for you or not. Partly it’s their tolerability. If
medication can cause a consistent adverse effect which you
don’t like, you’re not going to take it. I think it’s partly the
cost of the medications. If you have to pay, even if you’re on
a health care card, you have to pay a dispensing fee of $3
or whatever it is. And unfortunately, I think the Indigenous
patients are poorer. [1,2] Another specialist alluded to the
challenges of remote living: I think that compliance is
more difficult for people who live remotely. It’sj u s tm o r e
difficult for them and that doesn’t necessarily reflect [on]
the individual, it’s just it takes a greater level of commit-
ment to be able to comply in that environment.[ 1 - 8 ]
Cultural issues were also identified as reducing the likeli-
hood of maintaining treatment regimens, including differ-
ent approaches to time, life priorities, illness, action and
responsibility. For example, different approaches to time
and to life priorities were thought to factor largely in
missed dialysis and appointments. As one nephrologist
said: Aboriginal people don’t tend to think too much about
tomorrow or next week, they tend to be “now” people.
I think therefore it makes it more difficult for them some-
times to understand why they should be taking a tablet for
tomorrow. [1-3] Another, noting the large number of fun-
erals which people attend, said: so they don’tt u r nu p[ f o r
dialysis]. Someone’s died in their family - they go. Some of
these people go to funerals frequently because they’ve got
such a big family - so they don’tt u r nu p .A n dw ej u s t
accept that it’s part of their culture.[ 1 ]T h ec o m m e n t
inadvertently also highlights the level of illness and loss
experienced by Indigenous patients and their families.
The way in which non-compliance and social and cul-
tural circumstances were conflated in the nephrologists’
accounts revealed a common pattern of thinking whereby
individuals would be pre-judged as high-risk, with
accordingly reduced chances of referral. As one nephrol-
ogist observed: I think the perception of illness amongst
the Aboriginal people is very, very different, because the
perception of time is different and the perception of conse-
quence, of action, is also different - or inaction. I think
that really does cloud the whole issue of transplanting the
A b o r i g i n a lp a t i e n ta n de n s u r i n gc o m p l i a n c e...i tw o u l d
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some. [1-14]
Discussion
This study explored the views of Australian nephrolo-
gists on patient compliance and transplant suitability -
both generally and specifically in relation to Indigenous
Australians. These interviews afford a unique insight
into the complexities of selection and referral of suitable
patients and reveal subtle, yet pervasive, barriers to Indi-
genous patients’ receiving kidneys.
There was no evidence that nephrologists relied on a
common definition or shared understanding of the
notion of patient compliance. They did not use consistent
methods of assessing compliance, nor did they consider
any methods reliable or particularly useful. Despite it
being commonly cited, there was much uncertainty
about the predictive validity or value of dialysis compli-
ance to identify risky transplant candidates. While this
dilemma frustrated many nephrologists, there was a
sense of resignation that a poor predictor of outcome
was better than none. Indigenous patients were com-
monly identified as high-risk and as having relatively
poor post-transplant outcomes. Non-compliance with
dialysis, often conflated with social and cultural factors,
was enmeshed within accounts of Indigenous patients as
being ‘risky’ and was a commonly cited reason for cau-
tion in referring them. Without systematically measuring
compliance, it is difficult to substantiate or refute claims
about non-compliance or its relationship to outcomes.
Recognition of the scarcity of organs permeated the nar-
ratives, influencing thinking and referrals. In this context,
the nephrologists varied in their approach to decision-
making about suitability. Some weighed the perceived
risks and benefits for individual patients in isolation, while
others considered relative risk compared with other
patients. Another recent Australian study, investigating
nephrologists’ perspectives on waitlisting and allocation of
deceased donor kidneys for transplant [21], reported simi-
lar tensions. Tong and colleagues found that while
nephrologists flagged issues of equity and social justice as
important factors in transplant wait-listing and allocation
of organs, they felt obliged to refer ‘good’ patients for
transplantation in order to maintain their transplant cen-
tre’s reputation and furthermore that, in their opinion, the
responsibility for ensuring equitable access to transplanta-
tion resides with policy makers and the community. In
light of these variations in approach, the likelihood of Indi-
genous patients’ - generally considered high risk and non-
compliant - being referred could vary significantly depend-
ing on where and by whom they were being treated.
Furthermore, perceived non-compliance was conflated
with generalisations about patients’ social and cultural cir-
cumstances - a tendency which would likely result in
Indigenous patients being considered, almost by default, as
high-risk.
The perceived immutability of ‘cultural’ causes of non-
compliance might diminish nephrologists’ willingness to
recommend Indigenous patients for transplantation.
Previous studies of Australian renal care providers and
Indigenous ESKD patients suggest that perceptions of
non-compliance might stem from miscommunication in
cross-cultural encounters, a misalignment in the health
paradigms of patients and providers and a lack of appro-
priate patient education [15,22,23]. While recognising
and dealing appropriately with cultural difference is cru-
cial to effective health care provision, the possibility of
systemic stigmatisation of patients from minority groups
must also be monitored and managed [10,24].
Compounding these concerns are the conflicting views
of nephrologists about the relevance of compliance to
transplant suitability. Emphasis on the importance of per-
ceived compliance was undermined by the equally
widely-held view that pre-transplant compliance is a poor
predictor of post-transplant behaviour and outcome.
With little evidence of such an association [12-14], our
findings challenge the validity of factoring compliance so
strongly into decision-making and indicate a pressing
need for a reconsideration of current selection guidelines
and practices.
A further finding was the diversity in nephrologists’
views about achieving equitable distribution of kidneys.
Strongly opposing views were advocated, based both on
utilitarian theory - organs should be given to those who
would derive the greatest benefit - and egalitarian -
patients should have equal access and scarce resources
should be distributed according to need. While it is impor-
tant that this valuable resource is not wasted, there are
serious concerns with a strictly utilitarian approach
[24,25]. Ethically (as well as clinically) integrating consid-
erations of risk into patient selection requires wider atten-
tion and debate.
This study, drawing on the self-reported views, atti-
tudes and experiences of nephrologists, has limitations.
We deliberately explored only the health care provider’s
perspective, as the ‘problem of non-compliance’ is argu-
ably located within the culture and views of health care
providers, rather than in the views of the patients. The
incorporation of the views of a substantial number of
senior decision-makers currently managing the majority
of Australia’s Indigenous ESKD patients enables some
firm conjectures to be made about current clinical prac-
tice relating to compliance labelling.
Conclusions
Clinical decision-making relating to patient referral for
transplantation is complex. Due to the chronic scarcity
of organs, any changes to the criteria will necessarily
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Our findings draw attention to a lack of clear evidence
regarding predictors of transplant outcomes amongst
Indigenous Australians and regarding the use of ‘compli-
ance’ labelling. Our findings also highlight the need for
alternative service delivery models for Indigenous Aus-
tralian ESKD patients.
A transparent and fair system of patient selection should
be a key objective of organ transplantation programs. The
development of an agreed national approach to patient
selection and organ distribution would assist in realising
this goal. A second fundamental step would be the investi-
gation of particular selection criteria to ascertain their
relevance and validity in determining patient suitability for
transplant. The absence of a strong evidence base to sup-
port the inclusion of psychosocial criteria in clinical guide-
lines highlights the need for research to critically examine
the impact of inclusion of particular psychosocial charac-
teristics in assessment of recipient suitability. Is it reason-
able to withhold a transplant based upon an assessment of
ap a t i e n t ’s ‘compliance’, when there are clear disadvan-
tages for particular patient groups, particularly for Indi-
genous patients, and when serious concerns exist
regarding the legitimacy of using the concept of patient
compliance?
Associated with development of patient selection guide-
lines is the dearth of evidence relating to the most suitable
indicators of post-transplant risk and benefit for Indigen-
ous patients. This is a key issue underpinning the contin-
ued usage of the problematic concept of compliance in
decision-making about kidney transplant suitability. With-
out a good evidence-base, specialists must rely on inade-
quate criteria in predicting transplant outcomes for this
patient group. In light of the difficulties faced by Indigen-
ous patients in maintaining dialysis treatment, alternative
service delivery models that better address the health,
social and cultural needs of Indigenous patients should be
explored and tested. These service delivery models need to
be regionally specific to account for the great diversity in
settings and contexts across the country. In a wealthy
country, with a health system that underpins excellent
health outcomes for the majority of its citizens, inequitable
access to necessary care and inequitable health outcomes
for Indigenous Australians is a fundamentally important
and unanswered priority in policy making.
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